STAT+: Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle
Stat News • 3/23/2026
Summary
No summary yet.
Advertisement
Lindy Score Breakdown (V4.2)
5h
Age
1
Sources
from cluster
6
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier92% (0.5^6/48)
Hero EligibleYes
Story Timeline
- 2026-03-23STAT+: Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 3 sources
Breaking Similar stories
STAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path
Stat News • Today
STAT+: Pharmalittle: We’re reading about Iran war’s impact on pharma supply chain, a Pfizer Lyme vaccine, and more
Stat News • Today
STAT+: Insmed drug benefits patients with rare, bacterial lung disease, study shows
Stat News • Today
STAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
Stat News • 2 days ago
STAT+: Doctronic raises $40 million as race to apply AI in clinical care heats up
Stat News • Today
STAT+: Apogee Therapeutics data show long-acting eczema drug induced relief with less frequent injections
Stat News • Today
STAT+: Epic says it has uncovered rot in patient record sharing. Will HHS act?
Stat News • Today
STAT+: The intersection of ‘Apprentice’ and the No Surprises Act
Stat News • Today
STAT+: Sepsis hospitalizations have tripled in Massachusetts. Is it real or a billing game?
Stat News • 2 days ago
Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
Stat News • 2 days ago